And some investors don't, and you are correct, but most small companies, especially the biotech companies have no revenues, and are all driven by hope that their new formulary's will get FDA approval and work. No different here other than the funding, and for all accounts, this CEO has delivered on everything she said she would - and its about 1Q too early for a sales revelation, no matter how hard you keep beating that drum, although I am sure, you will see sales numbers when the next Q or K come out. Its just that simple. Too early to reveal anything without establishing the foundation first - and, the in-store CVS program hasn't even started yet - or I am sure you would have seen news out. Just the same old paid story from you.
